Changes in serum levels of heat shock protein 70 in preterm delivery and pre-eclampsia

Aim: The aim of this study was to investigate heat‐shock protein (Hsp)70 as a novel marker to evaluate the curative effects of treatment for preterm delivery high‐risk patients and pre‐eclampsia. Methods: After obtaining informed consent, serum samples were collected from 31 preterm delivery high‐ri...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The journal of obstetrics and gynaecology research 2005-02, Vol.31 (1), p.72-77
Hauptverfasser: Fukushima, Akimune, Kawahara, Hisao, Isurugi, Chizuko, Syoji, Tadahiro, Oyama, Rie, Sugiyama, Toru, Horiuchi, Saburo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 77
container_issue 1
container_start_page 72
container_title The journal of obstetrics and gynaecology research
container_volume 31
creator Fukushima, Akimune
Kawahara, Hisao
Isurugi, Chizuko
Syoji, Tadahiro
Oyama, Rie
Sugiyama, Toru
Horiuchi, Saburo
description Aim: The aim of this study was to investigate heat‐shock protein (Hsp)70 as a novel marker to evaluate the curative effects of treatment for preterm delivery high‐risk patients and pre‐eclampsia. Methods: After obtaining informed consent, serum samples were collected from 31 preterm delivery high‐risk patients with a tocolysis index of three points or above (A), seven pre‐eclampsia patients (P), 46 normal pregnant women (B), and seven non‐pregnant women (C). Of the 31 preterm delivery high‐risk patients, 15 had preterm delivery (Ap) and 16 had full‐term delivery (Af ). The levels of Hsp70 were measured using enzyme‐linked immunosorbent assay. Results: The Hsp70 levels in normal pregnant women were 8.6 ± 1.9 ng/mL (first trimester), 5.5 ± 1.0 ng/mL (second trimester) and 5.5 ± 0.7 ng/mL (third trimester). There was no statistical difference in the Hsp70 levels between the three trimesters. The mean Hsp70 levels were 21.9 ± 5.3 ng/mL (A), 35.3 ± 9.6 ng/mL (Ap), 9.4 ± 2.2 ng/mL (Af), 24.4 ± 3.6 ng/mL (P), 6.1 ± 0.6 ng/mL (B), and 2.4 ± 0.6 ng/mL (C). Group Ap had significantly higher Hsp70 levels than group Af (P = 0.0112) and group B (P 
doi_str_mv 10.1111/j.1447-0756.2005.00244.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67381899</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67381899</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5234-5805a0bb804b5196291c41781758bb84aef04131b849c3b5d945ab13a396cd9b3</originalsourceid><addsrcrecordid>eNqNkEFPwyAUx4nROJ1-BcPJWysUKJB40UWnZnGXqUdC2zfXrV0ndLp9e6lb9CoXXh6__-PlhxCmJKbhXM1jyrmMiBRpnBAiYkISzuPNATr5fTgMNeM0UkSmPXTq_ZwQKjVVx6hHRZpqreUJeh3M7PIdPC6X2INb17iCT6g8bqZ4BrbFftbkC7xyTQsBkaQDVw5acDUuoCo_wW2xXRZdM4K8svXKl_YMHU1t5eF8f_fRy_3dZPAQjcbDx8HNKMpFwngkFBGWZJkiPBNUp4mmOadSUSlU6HILU8Ipo6HUOctEobmwGWWW6TQvdMb66HI3Nyz4sQbfmrr0OVSVXUKz9iaVTFGldQDVDsxd472DqVm5srZuaygxnVMzN50606kznVPz49RsQvRi_8c6q6H4C-4lBuB6B3yVFWz_Pdg8jYehCPFoFy99C5vfuHWLbn0pzNvz0Nwmik8memBG7BsYuJLP</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67381899</pqid></control><display><type>article</type><title>Changes in serum levels of heat shock protein 70 in preterm delivery and pre-eclampsia</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Fukushima, Akimune ; Kawahara, Hisao ; Isurugi, Chizuko ; Syoji, Tadahiro ; Oyama, Rie ; Sugiyama, Toru ; Horiuchi, Saburo</creator><creatorcontrib>Fukushima, Akimune ; Kawahara, Hisao ; Isurugi, Chizuko ; Syoji, Tadahiro ; Oyama, Rie ; Sugiyama, Toru ; Horiuchi, Saburo</creatorcontrib><description>Aim: The aim of this study was to investigate heat‐shock protein (Hsp)70 as a novel marker to evaluate the curative effects of treatment for preterm delivery high‐risk patients and pre‐eclampsia. Methods: After obtaining informed consent, serum samples were collected from 31 preterm delivery high‐risk patients with a tocolysis index of three points or above (A), seven pre‐eclampsia patients (P), 46 normal pregnant women (B), and seven non‐pregnant women (C). Of the 31 preterm delivery high‐risk patients, 15 had preterm delivery (Ap) and 16 had full‐term delivery (Af ). The levels of Hsp70 were measured using enzyme‐linked immunosorbent assay. Results: The Hsp70 levels in normal pregnant women were 8.6 ± 1.9 ng/mL (first trimester), 5.5 ± 1.0 ng/mL (second trimester) and 5.5 ± 0.7 ng/mL (third trimester). There was no statistical difference in the Hsp70 levels between the three trimesters. The mean Hsp70 levels were 21.9 ± 5.3 ng/mL (A), 35.3 ± 9.6 ng/mL (Ap), 9.4 ± 2.2 ng/mL (Af), 24.4 ± 3.6 ng/mL (P), 6.1 ± 0.6 ng/mL (B), and 2.4 ± 0.6 ng/mL (C). Group Ap had significantly higher Hsp70 levels than group Af (P = 0.0112) and group B (P &lt; 0.0001). The duration of pregnancy after hospitalization for group Ap was significantly shorter than that for group Af (P = 0.0088) and group B (P &lt; 0.0001). Group P also had significantly higher Hsp70 levels than group B (P &lt; 0.0001). Conclusion: Because Hsp70 levels were particularly high in treatment‐resistant preterm delivery cases, Hsp70 may prove to be a useful marker for evaluating the curative effects of treatment for preterm delivery.</description><identifier>ISSN: 1341-8076</identifier><identifier>EISSN: 1447-0756</identifier><identifier>DOI: 10.1111/j.1447-0756.2005.00244.x</identifier><identifier>PMID: 15669997</identifier><language>eng</language><publisher>Melbourne, Australia: Blackwell Science Pty</publisher><subject>Adult ; Biomarkers - blood ; Case-Control Studies ; Female ; Gestational Age ; heat shock protein 70 ; HSP70 Heat-Shock Proteins - blood ; Humans ; Obstetric Labor, Premature - blood ; Parity ; pre-eclampsia ; Pre-Eclampsia - blood ; Predictive Value of Tests ; Pregnancy ; Pregnancy Trimesters - blood ; preterm delivery</subject><ispartof>The journal of obstetrics and gynaecology research, 2005-02, Vol.31 (1), p.72-77</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5234-5805a0bb804b5196291c41781758bb84aef04131b849c3b5d945ab13a396cd9b3</citedby><cites>FETCH-LOGICAL-c5234-5805a0bb804b5196291c41781758bb84aef04131b849c3b5d945ab13a396cd9b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1447-0756.2005.00244.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1447-0756.2005.00244.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15669997$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fukushima, Akimune</creatorcontrib><creatorcontrib>Kawahara, Hisao</creatorcontrib><creatorcontrib>Isurugi, Chizuko</creatorcontrib><creatorcontrib>Syoji, Tadahiro</creatorcontrib><creatorcontrib>Oyama, Rie</creatorcontrib><creatorcontrib>Sugiyama, Toru</creatorcontrib><creatorcontrib>Horiuchi, Saburo</creatorcontrib><title>Changes in serum levels of heat shock protein 70 in preterm delivery and pre-eclampsia</title><title>The journal of obstetrics and gynaecology research</title><addtitle>J Obstet Gynaecol Res</addtitle><description>Aim: The aim of this study was to investigate heat‐shock protein (Hsp)70 as a novel marker to evaluate the curative effects of treatment for preterm delivery high‐risk patients and pre‐eclampsia. Methods: After obtaining informed consent, serum samples were collected from 31 preterm delivery high‐risk patients with a tocolysis index of three points or above (A), seven pre‐eclampsia patients (P), 46 normal pregnant women (B), and seven non‐pregnant women (C). Of the 31 preterm delivery high‐risk patients, 15 had preterm delivery (Ap) and 16 had full‐term delivery (Af ). The levels of Hsp70 were measured using enzyme‐linked immunosorbent assay. Results: The Hsp70 levels in normal pregnant women were 8.6 ± 1.9 ng/mL (first trimester), 5.5 ± 1.0 ng/mL (second trimester) and 5.5 ± 0.7 ng/mL (third trimester). There was no statistical difference in the Hsp70 levels between the three trimesters. The mean Hsp70 levels were 21.9 ± 5.3 ng/mL (A), 35.3 ± 9.6 ng/mL (Ap), 9.4 ± 2.2 ng/mL (Af), 24.4 ± 3.6 ng/mL (P), 6.1 ± 0.6 ng/mL (B), and 2.4 ± 0.6 ng/mL (C). Group Ap had significantly higher Hsp70 levels than group Af (P = 0.0112) and group B (P &lt; 0.0001). The duration of pregnancy after hospitalization for group Ap was significantly shorter than that for group Af (P = 0.0088) and group B (P &lt; 0.0001). Group P also had significantly higher Hsp70 levels than group B (P &lt; 0.0001). Conclusion: Because Hsp70 levels were particularly high in treatment‐resistant preterm delivery cases, Hsp70 may prove to be a useful marker for evaluating the curative effects of treatment for preterm delivery.</description><subject>Adult</subject><subject>Biomarkers - blood</subject><subject>Case-Control Studies</subject><subject>Female</subject><subject>Gestational Age</subject><subject>heat shock protein 70</subject><subject>HSP70 Heat-Shock Proteins - blood</subject><subject>Humans</subject><subject>Obstetric Labor, Premature - blood</subject><subject>Parity</subject><subject>pre-eclampsia</subject><subject>Pre-Eclampsia - blood</subject><subject>Predictive Value of Tests</subject><subject>Pregnancy</subject><subject>Pregnancy Trimesters - blood</subject><subject>preterm delivery</subject><issn>1341-8076</issn><issn>1447-0756</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkEFPwyAUx4nROJ1-BcPJWysUKJB40UWnZnGXqUdC2zfXrV0ndLp9e6lb9CoXXh6__-PlhxCmJKbhXM1jyrmMiBRpnBAiYkISzuPNATr5fTgMNeM0UkSmPXTq_ZwQKjVVx6hHRZpqreUJeh3M7PIdPC6X2INb17iCT6g8bqZ4BrbFftbkC7xyTQsBkaQDVw5acDUuoCo_wW2xXRZdM4K8svXKl_YMHU1t5eF8f_fRy_3dZPAQjcbDx8HNKMpFwngkFBGWZJkiPBNUp4mmOadSUSlU6HILU8Ipo6HUOctEobmwGWWW6TQvdMb66HI3Nyz4sQbfmrr0OVSVXUKz9iaVTFGldQDVDsxd472DqVm5srZuaygxnVMzN50606kznVPz49RsQvRi_8c6q6H4C-4lBuB6B3yVFWz_Pdg8jYehCPFoFy99C5vfuHWLbn0pzNvz0Nwmik8memBG7BsYuJLP</recordid><startdate>200502</startdate><enddate>200502</enddate><creator>Fukushima, Akimune</creator><creator>Kawahara, Hisao</creator><creator>Isurugi, Chizuko</creator><creator>Syoji, Tadahiro</creator><creator>Oyama, Rie</creator><creator>Sugiyama, Toru</creator><creator>Horiuchi, Saburo</creator><general>Blackwell Science Pty</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200502</creationdate><title>Changes in serum levels of heat shock protein 70 in preterm delivery and pre-eclampsia</title><author>Fukushima, Akimune ; Kawahara, Hisao ; Isurugi, Chizuko ; Syoji, Tadahiro ; Oyama, Rie ; Sugiyama, Toru ; Horiuchi, Saburo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5234-5805a0bb804b5196291c41781758bb84aef04131b849c3b5d945ab13a396cd9b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Adult</topic><topic>Biomarkers - blood</topic><topic>Case-Control Studies</topic><topic>Female</topic><topic>Gestational Age</topic><topic>heat shock protein 70</topic><topic>HSP70 Heat-Shock Proteins - blood</topic><topic>Humans</topic><topic>Obstetric Labor, Premature - blood</topic><topic>Parity</topic><topic>pre-eclampsia</topic><topic>Pre-Eclampsia - blood</topic><topic>Predictive Value of Tests</topic><topic>Pregnancy</topic><topic>Pregnancy Trimesters - blood</topic><topic>preterm delivery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fukushima, Akimune</creatorcontrib><creatorcontrib>Kawahara, Hisao</creatorcontrib><creatorcontrib>Isurugi, Chizuko</creatorcontrib><creatorcontrib>Syoji, Tadahiro</creatorcontrib><creatorcontrib>Oyama, Rie</creatorcontrib><creatorcontrib>Sugiyama, Toru</creatorcontrib><creatorcontrib>Horiuchi, Saburo</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The journal of obstetrics and gynaecology research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fukushima, Akimune</au><au>Kawahara, Hisao</au><au>Isurugi, Chizuko</au><au>Syoji, Tadahiro</au><au>Oyama, Rie</au><au>Sugiyama, Toru</au><au>Horiuchi, Saburo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Changes in serum levels of heat shock protein 70 in preterm delivery and pre-eclampsia</atitle><jtitle>The journal of obstetrics and gynaecology research</jtitle><addtitle>J Obstet Gynaecol Res</addtitle><date>2005-02</date><risdate>2005</risdate><volume>31</volume><issue>1</issue><spage>72</spage><epage>77</epage><pages>72-77</pages><issn>1341-8076</issn><eissn>1447-0756</eissn><abstract>Aim: The aim of this study was to investigate heat‐shock protein (Hsp)70 as a novel marker to evaluate the curative effects of treatment for preterm delivery high‐risk patients and pre‐eclampsia. Methods: After obtaining informed consent, serum samples were collected from 31 preterm delivery high‐risk patients with a tocolysis index of three points or above (A), seven pre‐eclampsia patients (P), 46 normal pregnant women (B), and seven non‐pregnant women (C). Of the 31 preterm delivery high‐risk patients, 15 had preterm delivery (Ap) and 16 had full‐term delivery (Af ). The levels of Hsp70 were measured using enzyme‐linked immunosorbent assay. Results: The Hsp70 levels in normal pregnant women were 8.6 ± 1.9 ng/mL (first trimester), 5.5 ± 1.0 ng/mL (second trimester) and 5.5 ± 0.7 ng/mL (third trimester). There was no statistical difference in the Hsp70 levels between the three trimesters. The mean Hsp70 levels were 21.9 ± 5.3 ng/mL (A), 35.3 ± 9.6 ng/mL (Ap), 9.4 ± 2.2 ng/mL (Af), 24.4 ± 3.6 ng/mL (P), 6.1 ± 0.6 ng/mL (B), and 2.4 ± 0.6 ng/mL (C). Group Ap had significantly higher Hsp70 levels than group Af (P = 0.0112) and group B (P &lt; 0.0001). The duration of pregnancy after hospitalization for group Ap was significantly shorter than that for group Af (P = 0.0088) and group B (P &lt; 0.0001). Group P also had significantly higher Hsp70 levels than group B (P &lt; 0.0001). Conclusion: Because Hsp70 levels were particularly high in treatment‐resistant preterm delivery cases, Hsp70 may prove to be a useful marker for evaluating the curative effects of treatment for preterm delivery.</abstract><cop>Melbourne, Australia</cop><pub>Blackwell Science Pty</pub><pmid>15669997</pmid><doi>10.1111/j.1447-0756.2005.00244.x</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1341-8076
ispartof The journal of obstetrics and gynaecology research, 2005-02, Vol.31 (1), p.72-77
issn 1341-8076
1447-0756
language eng
recordid cdi_proquest_miscellaneous_67381899
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Adult
Biomarkers - blood
Case-Control Studies
Female
Gestational Age
heat shock protein 70
HSP70 Heat-Shock Proteins - blood
Humans
Obstetric Labor, Premature - blood
Parity
pre-eclampsia
Pre-Eclampsia - blood
Predictive Value of Tests
Pregnancy
Pregnancy Trimesters - blood
preterm delivery
title Changes in serum levels of heat shock protein 70 in preterm delivery and pre-eclampsia
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T12%3A51%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Changes%20in%20serum%20levels%20of%20heat%20shock%20protein%2070%20in%20preterm%20delivery%20and%20pre-eclampsia&rft.jtitle=The%20journal%20of%20obstetrics%20and%20gynaecology%20research&rft.au=Fukushima,%20Akimune&rft.date=2005-02&rft.volume=31&rft.issue=1&rft.spage=72&rft.epage=77&rft.pages=72-77&rft.issn=1341-8076&rft.eissn=1447-0756&rft_id=info:doi/10.1111/j.1447-0756.2005.00244.x&rft_dat=%3Cproquest_cross%3E67381899%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67381899&rft_id=info:pmid/15669997&rfr_iscdi=true